fibrinogen has been researched along with Lung Neoplasms in 193 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 75 (38.86) | 18.7374 |
1990's | 27 (13.99) | 18.2507 |
2000's | 21 (10.88) | 29.6817 |
2010's | 46 (23.83) | 24.3611 |
2020's | 24 (12.44) | 2.80 |
Authors | Studies |
---|---|
Aine, M; Arbajian, E; Arslan, T; Berkovska, O; Branca, RM; Brunnström, H; Brustugun, OT; Cunningham, R; Drageset Haakensen, V; Foroughi Asl, H; Gram Hansen, C; Helland, Å; Isaksson, S; Johansson, HJ; Jönsson, M; Karlsson, A; Kotevska, M; Lehtiö, J; Mermelekas, G; Orre, LM; Pan, Y; Pirmoradian, M; Planck, M; Purohit, KP; Siavelis, I; Socciarelli, F; Staaf, J; Tamborero, D; Umer, HM | 1 |
Hu, C; Song, Y; Wang, N; Xu, X; Zhang, T | 1 |
Doi, T; Hokka, D; Maniwa, Y; Mitsui, S; Tanaka, Y | 1 |
Inoue, M; Ishihara, S; Iwasaki, M | 1 |
Inoue, M; Ishihara, S; Iwasaki, M; Okada, S; Shimegi, R; Shimomura, M | 1 |
Adane, T; Aynalem, M; Bayleyegn, B; Getawa, S; Kifle, ZD | 1 |
Jiang, T; Liu, YJ; Ma, N; Shi, AP; Shu, C; Tang, XY; Xiong, YL; Yang, J; Zhao, JB; Zhao, YB; Zheng, KF | 1 |
Gompelmann, D; Grusch, M; Hoda, MA; Hoetzenecker, K; Klepetko, W; Klikovits, T; Mosleh, B; Sinn, K | 1 |
Liu, Y; Wang, L; Zhao, X; Zheng, H; Zhu, C | 1 |
Han, Y; Hiratsuka, S; Kato, M; Tomita, T; Yin, C | 1 |
Dai, J; Jiang, G; Jin, K; Li, Z; Song, X; Yang, F; Zhou, B; Zhu, X; Zhu, Y | 1 |
Gong, S; Yao, X | 1 |
Huang, ZN; Tao, SM; Wang, GX; Xie, MR; Xu, MQ; Ye, YQ; Zhang, M | 1 |
Li, N; Liao, Z; Shao, G; Zheng, R | 1 |
Deng, Y; Jiang, N; Li, P; Li, Y; Luo, J; Tian, Z; Xiao, Z; Zhang, W; Zhao, J; Zhao, X; Zhao, Y; Zhou, J; Zhou, Y | 1 |
Funai, K; Inoue, Y; Iwashita, Y; Kurono, N; Ogawa, H; Ohta, T; Shinmura, K; Suda, T; Sugimura, H; Tsuchiya, K; Watanabe, T; Yamada, H; Yoshimura, K | 1 |
An, GY; Bian, NN; Feng, GS; Ge, Y; Hu, X; Qi, HY; Shi, XY | 1 |
Kuang, M; Mao, H; Peng, Y; Sun, Y; Tao, X; Zhang, H; Zhou, Z; Zhuge, L | 1 |
Cao, C; Jiang, X; Liu, S; Lu, S; Niu, X; Qiao, Z; Shang, Z; Xiao, H; Zhang, K | 1 |
Cao, J; Deng, Y; Dong, M; Huang, Y; Huang, Z; Li, R; Lin, G; Zhang, Y | 1 |
Chiba, M; Fujino, T; Hamada, A; Koga, T; Mitsudomi, T; Nishino, M; Ohara, S; Sato, K; Shimoji, M; Soh, J; Suda, K; Takemoto, T; Tomizawa, K | 1 |
Cheng, H; Gao, W; Hao, J; Liu, J; Sun, C | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
He, J; Wang, X; Xiao, R; Yao, H; Zhang, W; Zuo, W | 1 |
He, Q; Hu, A; Li, J; Li, Y; Peng, S; Xia, C; Zhang, R; Zhang, Z; Zhou, W; Zhou, X | 1 |
Hiratsuka, S; Kato, M; Tomita, T | 1 |
Cheng, Y; Li, K; Meng, Z; Wang, J; Wang, X; Zhang, C | 1 |
Chen, L; Guo, B; Hu, C; Yang, F; Zha, H; Zhang, L; Zhu, B; Zhu, Y | 1 |
An, G; Fan, S; Guan, Y; Zhao, G | 1 |
Chen, QG; Gao, QF; Jiang, YH; Li, SQ; Lin, J; Sun, F; Wang, XZ; Ying, HQ; Zhang, J; Zhang, L | 1 |
Chen, S; Du, J; Li, J; Shen, B; Yan, H; Ying, H; Zhang, Y | 1 |
Aburatani, H; High, KA; Hiratsuka, S; Hosogane, T; Ishibashi, S; Maru, Y; Matsunaga, Y; Mishima, T; Omori, T; Omori-Miyake, M; Shibata, N; Tomita, T; Tomura, M; Watanabe, A; Watarai, H; Yamaguchi, S; Yamamoto, T | 1 |
Chen, L; Hou, C; Jiang, F; Li, J; Luo, X; Ma, H; Qian, Y; Tan, S; Wang, Z; Xu, X; Xue, T; Yang, R; Zhao, B; Zhao, M; Zhu, Q | 1 |
Al-Saudi, R; Graham, A; Hamid, UI; Paul, I | 1 |
Gu, T; Huang, J; Liu, H; Ying, J; Zhou, D | 1 |
Bugert, P; González Maldonado, S; Grafetstätter, M; Hoffmeister, M; Hüsing, A; Johnson, T; Kaaks, R; Katzke, VA; Kühn, T; Pletsch-Borba, L; Sookthai, D | 1 |
Amir, ZC; Aouichat-Bouguerra, S; Ferhat-Hamida, MY; Hammouda, A; Hariti, G; Souilah, S | 1 |
Bie, F; Du, J; Huang, C; Qu, X; Wang, G; Wang, Y | 1 |
Filosso, PL; Giobbe, R; Lausi, PO; Oliaro, A; Ruffini, E; Sandri, A | 1 |
Cho, S; Lee, E; Seok, Y | 1 |
Hajj-Chahine, J | 1 |
Chen, L; Gao, X; Li, C; Liang, Y; Liu, X; Lv, Y; Tian, Q; Yang, Z; Zhao, W | 1 |
Lin, N; Luo, M; Mao, W; Sheng, L; Su, D; Sun, X | 1 |
Cai, L; Rong, TH; Su, XD; Wen, YS; Zhang, LJ; Zhang, XW; Zhu, JF | 1 |
Hamano, A; Jin, T; Ohno, N; Ohno, S; Okumura, N; Saiki, I; Saitoh, Y; Terada, N | 1 |
Alimohammadi, A; Arns, M; Berger, W; Brcic, L; Dome, B; Filipits, M; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Klepetko, W; Klikovits, T; Laszlo, V; Samarzija, M; Schenk, P; Winter, MP | 1 |
Han, SK; Kim, KH; Kim, YW; Lee, JY; Lee, SM; Park, TY; Yang, SC; Yim, JJ; Yoo, CG | 1 |
Chen, P; Ge, LP; Jiang, HG; Jiang, Q; Li, J; Shi, SB; Tang, XP | 1 |
Araújo, AS; Da Silva, GP; De Moraes Filho, MO; Mesquita, R; Morano, MT; Neto, AG; Pereira, ED; Pinto, JM; Viana, CM | 1 |
Jilma, B; Kulinna-Cosentini, C; Laggner, A; Röggla, M; Schober, A; Schörgenhofer, C; Schwameis, M; Thaler, J | 1 |
Cui, L; Hong, L; Li, Y; Wang, C; Wang, J; Wei, S | 1 |
Davidson, SJ; Davies, NA; Evans, PA; Evans, VJ; Harrison, NK; Hawkins, K; Lawrence, MJ; Morris, RH; Noble, S; Sabra, A; Williams, PR | 1 |
Chen, P; Jiang, Q; Li, J; Tang, XP; Zhu, LR | 1 |
Kabat, GC; Lane, DS; Rohan, TE; Salazar, CR; Zaslavsky, O | 1 |
Araújo, AS; da Silva, GP; de Medeiros, IL; De Moraes Filho, MO; Gomes Neto, A; Morano, MT; Nogueira, IC; Pereira, ED; Santos, FA | 1 |
Dyszkiewicz, W; Hajduk, J; Klupczynska, A; Kokot, ZJ; Matysiak, J; Pawlak, K; Swiatly, A | 1 |
Gong, P; Liu, CH; Yang, J | 1 |
Aigner, C; Bendek, M; Berger, W; Brcic, L; Dome, B; Dong, Y; Frauenfelder, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Kao, SC; Kirschner, MB; Klepetko, W; Klikovits, T; Laszlo, V; Nguyen-Kim, TD; Opitz, I; Ozsvar, J; Reid, G; Rozsas, A; Samarzija, M; Stockhammer, P; Szirtes, I; van Zandwijk, N; Weder, W | 1 |
Higashiyama, M; Ishida, H; Kodama, K; Kusu, T; Okami, J; Tokunaga, T | 1 |
Christensen, TD; Hornbech, K; Hvas, AM; Licht, PB; Nybo, M; Pedersen, S; Vad, H; Zois, NE | 1 |
Brüggemann, LW; Buckle, T; Klerk, CP; Muller, FJ; Niers, TM; Reitsma, PH; Richel, DJ; Spek, CA; Van Noorden, CJ; Van Tellingen, O | 1 |
Blom, AM; Corrales, L; Okroj, M; Pio, R; Stokowska, A | 1 |
Kitayama, J; Nagawa, H; Taguri, M; Yamashita, H | 1 |
Sanfelippo, MJ; Scherr, DL; Shaw, GR; Zinsmaster, W | 1 |
Casadio, C; Massera, F; Mineo, TC; Papalia, E; Pirondini, E; Rena, O; Turello, D | 1 |
De Stavola, BL; dos Santos Silva, I; Meade, TW; Pizzi, C | 1 |
Csekeo, A; Dango, S; Dienemann, H; Facciolo, F; Klepetko, W; Ladegaard, L; Marta, GM; Rea, F; Spaggiari, L; Tetens, V | 1 |
Fu, X; Xu, C | 1 |
Brüggemann, LW; Büller, HR; Esmon, CT; Kamphuisen, PW; Richel, DJ; Spek, CA; van Noorden, CJ; van Sluis, GL | 1 |
Brodhun, M; Goldbrunner, R; Handel, LL; Hanisch, UK; Heppner, F; Koch, A; Kuhn, SA; Liebmann, L; van Rossum, D; Walter, J | 1 |
Ceylan, E; Cildag, O; Gulen, ST; Karadag, F; Karul, AB; Kilicarslan, N; Kuman, NK | 1 |
Huang, X; Shen, J; Shen, Y; Wang, C; Wang, Z; Ying, K | 1 |
Hu, X; Jin, B; Li, H; Liu, Y; Luo, Y; Qu, X; Teng, Y; Yu, P; Zhang, J; Zhang, L; Zhao, J; Zhao, M; Zheng, S; Zhou, Q | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
MacNee, W | 1 |
Bayer, E; Gelbmann, D; Gerner, C; Peter, B; Posovszky, C; Schulte-Hermann, R; Vejda, S; Zelzer, S | 1 |
Degen, JL; Jackson, DG; Kaplan, LS; Palumbo, JS; Potter, JM; Talmage, K | 1 |
KORST, DR; KRATOCHVIL, CH | 1 |
EVANS, TS; O'NEILL, JJ | 1 |
BANHIDI, E; MARCZ, I; OSVATH, S | 1 |
BOROS, M; GABOR, M; KULKA, F | 1 |
AMRIS, A; AMRIS, CJ | 1 |
DANTSIG, II | 1 |
Czerny, M; Fleck, T; Klepetko, W; Mueller, MR; Salat, A; Wolner, E; Zimpfer, D | 1 |
Bajzar, L; Blajchman, MA; Clarke, BJ; Hatton, MW; Legault, KJ; Richardson, M; Ross, BL; Singh, G; Southward, SM | 1 |
Chen, M; Wu, XM; Yuan, JY; Yuan, XZ; Zhang, SS | 1 |
Janowska-Wieczorek, A; Kijowski, J; Machalinski, B; Marquez-Curtis, L; Ratajczak, J; Ratajczak, MZ; Wysoczynski, M | 1 |
Bhatia, SK; Fu, W; Hammer, DA; Im, JH; Kowalska, MA; Muschel, RJ; Wang, H | 1 |
Cran, GW; Graham, AN; Jones, JM; McAnespie, M; McGonigle, NC | 1 |
Kim, JH; Kim, MS; Lee, HS; Lee, JM; Nam, BH; Song, SW; Zo, JI | 1 |
Akakura, N; Cheung, AT; Hoogland, C; Liu, FT; Saegusa, J; Takada, Y; Takada, YK; Ye, X | 1 |
Altiay, G; Caglar, T; Ciftci, A; Demir, M; Hatipoglu, ON; Kocak, Z; Sut, N; Tabakoglu, E | 1 |
Francis, CW; Sahni, A; Sahni, SK; Simpson-Haidaris, PJ; Vaday, GG | 1 |
Bartos, V; Brzek, V; Chrobák, L; Hnízdová, D | 1 |
Bube, FW; Egenolf, F | 1 |
Helin, H; Mustonen, J; Pasternack, A | 1 |
Gerdin, B; Kopeć, M; Roszkowski, W; Saldeen, T; Stachurska, J | 1 |
Cherubino, R; Giraldi, T; Mitri, E; Sava, G | 1 |
Barb, C; Cronlund, M; Edwards, RL; Rickles, FR | 1 |
Murakoshi, T | 1 |
Chmielewska, J; Donati, MB; Janik, P; Latallo, ZS; Poggi, A | 1 |
Agostino, D; Agostino, N | 1 |
Chmielewska, J; Donati, MB; Garattini, S; Mussoni, L; Poggi, A | 1 |
Bartsch, HH; Beyer, JH; Borghardt, J; Brockmeyer, J; Kaboth, U; Kehl, A; Klee, M; Köstering, H; Krieger, G; Nagel, GA | 1 |
Kanayama, M; Matsui, N; Miura, H; Shimase, J; Suzuki, S | 1 |
Alessandri, G; De Bellis Vitti, G; Delaini, F; Donati, MB; Giavazzi, R; Mantovani, A | 1 |
Gabazza, E; Ibata, H; Machishi, M; Suzuki, S; Taguchi, O; Yamakami, T | 1 |
Ding, YP; Feng, BY; Ma, ZF | 1 |
Wang, XM; Wang, YT; Yu, RC | 1 |
Haku, T; Ogura, T; Shinohara, T; Sone, S; Takahashi, Y; Yanagawa, H; Yano, S | 1 |
Meehan, KR; Moritz, TE; Rickles, FR; Zacharski, LR | 1 |
Hama, T; Iwai, Y; Kawasaki, K; Mayumi, T; Nakagawa, S; Namikawa, M; Tsutsumi, Y; Yamamoto, S; Yamashiro, Y | 1 |
Hayashi, S; Ito, M; Mori, M; Nakagawa, M; Nishikawa, H; Ogura, T; Sakuma-Mochizuki, J; Takeuchi, E; Yamaguchi, T; Yokota, S | 1 |
Haidaris, PJ | 1 |
Chen, W; Fahn, HJ; Huang, MH; Wang, LS; Whang-Peng, J; Wu, YC | 1 |
Amedeo, C; Biroccio, A; Bucci, B; Del Bufalo, D; Falcioni, R; Leonetti, C; Zupi, G | 1 |
Chahinian, AP; Higashino, K; Miyake, M; Nakano, T; Ninomiya, K; Shinjo, M; Togawa, N; Tonomura, A | 1 |
Geerards, S; Meijer, K; Smid, WM; van der Meer, J | 1 |
Ito, M; Nakagawa, M; Ogura, T; Yamaguchi, T; Yamamoto, Y; Yokota, S | 1 |
Bardossy, L; Blajchman, MA; DeReske, M; Hatton, MW; Richardson, M; Ross, B; Southward, SM | 1 |
Hashimoto, T; Ito, M; Kimura, H; Nakagawa, M; Ogura, T; Yamaguchi, T; Yamamoto, Y; Yokota, S | 1 |
Lee, SY; Park, LO; Suk, SH | 1 |
Bugge, TH; Degen, JL; Drew, AF; Grimes, TS; Kiser, JH; Kombrinck, KW; Palumbo, JS | 1 |
Hawson, GA; Marsh, NA; Pavey, SJ | 1 |
Ivarsson, L | 1 |
Ambrus, CM; Ambrus, JL; Bross, I; Pickern, J; Soldes, S | 1 |
Gastpar, H | 1 |
Kashibayashi, Y; Kawakatsu, K; Sugimura, M | 1 |
Benedetta Donati, M; de Gaetano, G; Garattini, S; Poggi, A; Polentarutti, N | 1 |
Glauser, FL; Levine, RI; Otis, PT; Smith, WR | 1 |
Edwards, RL; Hur, K; Moritz, TE; Rickles, FR; Wojtukiewicz, MZ; Zacharski, LR | 1 |
Fukuroi, T; Kido, H; Kokawa, T; Nomura, S; Soga, T; Yamaguchi, K; Yanabu, M; Yasunaga, K | 1 |
Hayashi, S; Hirano, H; Ichinose, Y; Kawasaki, M; Miyagawa, Y; Nakanishi, M; Nomoto, Y; Ogino, H; Tanaka, K; Yagawa, K | 1 |
Atagi, S; Fukuta, K; Ogura, T; Sone, S | 1 |
Kjaergard, HK; Rygg, I; Sørensen, H; Thiis, J; Weis-Fogh, US | 1 |
Wajima, T | 1 |
Lyberg, T; Nakstad, B | 1 |
Hayashi, S; Ogata, K; Ogino, H; Yagawa, K | 1 |
Ambartsumian, AM; Khachaturova, TS; Magakian, AG; Mkrtchian, LN; Sarkisian, OM; Shukurian, SG | 1 |
Kisiel, W; Kudryk, BJ; Memoli, VA; Rousseau, SM; Stump, DC; Wojtukiewicz, MZ; Zacharski, LR | 1 |
Clorius, JH; Conrad, D; Hauser, H; Hull, WE; Maier-Borst, W; Manke, HG; Matys, ER; Schuhmacher, JH; Zuna, I | 1 |
Aoyama, A; Baba, M; Iizuka, K; Kawachi, S; Niitani, H; Nukariya, N; Ohtsuka, M; Sakai, S; Shibuya, M | 1 |
Kawahara, T; Kido, T; Sakamoto, I; Shindoh, T; Sugitachi, A | 1 |
Engelmann, C; Klemann, A; Straub, H | 1 |
Funai, T; Ikushima, Y; Saotome, K; Watanabe, T | 1 |
Cheresh, DA; Cooper, HM; Quaranta, V; Smith, JW | 1 |
Akaogi, E; Endo, S; Hori, M; Ishikawa, S; Mitsui, K; Sohara, Y | 1 |
Hara, N; Hayashi, S; Ichinose, Y; Iwami, T; Kinjo, M; Maruyama, M; Nakanishi, M; Ogata, K; Ohta, M; Yagawa, K | 1 |
Memoli, VA; Rousseau, SM; Zacharski, LR | 1 |
Cortés, JM; Oliva, H; Ordi Majá, J; Sarasa Corral, JL | 1 |
Bruhn, HD; Pheiffer, KF; Zurborn, KH | 1 |
Collen, D; Lijnen, HR; Stump, DC | 1 |
Kawachi, S | 1 |
George, WD; McCulloch, P | 1 |
Aoyama, A; Baba, M; Hirata, K; Kawachi, S; Matsusaka, M; Murata, A; Niitani, H; Ohtsuka, M; Shibuya, M; Yano, T | 1 |
Jessen, C; Sharma, P | 1 |
Hirata, H; Tanaka, K | 2 |
Alving, BM; Barr, CF; Dawson, NA | 1 |
Canellos, GP; Engelman, K; Hull, E; O'Connor, GT; Primack, A; Wilson, J | 1 |
Ambrus, JL; Brugarolas, A; Elias, EG; Mink, IB; Mittelman, A; Takita, H | 1 |
Bergut, FA; Daniel'-Bek, KV; Minaeva, EL; Sokolova, II; Trakhtenberg, AKh | 1 |
Rieche, K | 1 |
Bowie, EJ; Elveback, LR; Hagedorn, AB; Owen, CA | 1 |
Brugarolas, A; Elias, EG | 1 |
Elias, EG | 1 |
Cohen, MH | 1 |
Bowie, EJ; Owen, CA | 1 |
Carlsson, S | 1 |
Negreĭ, LN; Sopotsinskaia, EB | 1 |
Gordon-Smith, EC; Hilgard, P | 1 |
Kostiuchenko, AL; Shanin, IuN; Solov'eva, OV | 1 |
Shapovalov, ES | 1 |
Hirao, F; Ogura, T; Tsubura, E; Yamamura, Y | 1 |
Fukunaga, K; Nagamatsu, S; Nagashima, A; Yamada, T; Yamamoto, M | 1 |
Gormsen, J; Laursen, B | 1 |
Lebedeva, RN; Zaikina, LV | 1 |
Evdokimov, NM; Strashinin, AI; Zlydnikov, DM | 1 |
Azzopardi, JG; Baker, LR; Brain, MC; Dacie, JV; Pineo, GF; Roberts, PD | 1 |
Ogura, T; Tsubura, E; Yamamura, Y | 1 |
Kennedy, JH | 1 |
Agostino, D | 2 |
Voprontsova, GV | 1 |
Niewiadomska, S; Sierawski, S; Sosnowski, K | 1 |
Bergut, FA; Gorodilova, VV; Saraeva, ZM | 1 |
Agostino, D; Cliffton, EE | 1 |
Ignasiak, J; Lukaszczyk, E; Radecki, A | 1 |
Kosmala, U; Niewiadomska, S; Plamieniak, Z | 1 |
Dumont, AE; Shinowara, GY; Stutman, LJ | 1 |
Grigor'eva, VI; Tsigel'nik, AIa | 1 |
Spar, IL | 1 |
Grigorian, AV | 1 |
8 review(s) available for fibrinogen and Lung Neoplasms
Article | Year |
---|---|
Coagulation parameters in lung cancer patients: A systematic review and meta-analysis.
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung Neoplasms | 2022 |
Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; China; Disease-Free Survival; Fibrinogen; Humans; Lung Neoplasms; Prognosis; Progression-Free Survival; Survival Analysis | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Regulation of vascular permeability in cancer metastasis.
Topics: Animals; Capillary Permeability; Fibrinogen; Gene Expression Regulation, Neoplastic; Glycocalyx; Humans; Lung Neoplasms; Mice | 2021 |
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
Topics: Adiponectin; Aging; Airway Remodeling; Biomarkers; C-Reactive Protein; Cachexia; Cardiovascular Diseases; CD40 Ligand; Chemokines, CC; Cytokines; Desmosine; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isodesmosine; Lung Neoplasms; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Osteoprotegerin; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Serum Amyloid A Protein; Severity of Illness Index; Telomere; Uteroglobin | 2013 |
[Malignant neoplasms and thromboses].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhagic Disorders; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Thromboembolism | 1976 |
Signs and symptoms of bronchogenic carcinoma.
Topics: Adenocarcinoma; Blood Protein Disorders; Brain Diseases; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cerebellar Diseases; Cold Temperature; Endocarditis; Fibrinogen; Humans; Lung Neoplasms; Myasthenia Gravis; Myositis; Neoplasm Metastasis; Osteoarthropathy, Secondary Hypertrophic; Peripheral Nervous System Diseases; Skin Diseases; Thoracic Neoplasms; Thrombophlebitis | 1974 |
Chronic intravascular coagulation syndromes. A summary.
Topics: Blood Coagulation; Bone Marrow; Chronic Disease; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Liver; Lung Neoplasms; Male; Prostatic Neoplasms; Surgical Procedures, Operative | 1974 |
11 trial(s) available for fibrinogen and Lung Neoplasms
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer.
Topics: Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Fibrinogen; gamma-Glutamyltransferase; Humans; Indoles; Lactate Dehydrogenases; Lung Neoplasms; Phosphopyruvate Hydratase; Progression-Free Survival; Quinolines; Small Cell Lung Carcinoma; Treatment Outcome | 2021 |
Efficacy and safety of human fibrinogen-thrombin patch (TachoSil®) in the treatment of postoperative air leakage in patients submitted to redo surgery for lung malignancies: a randomized trial.
Topics: Adult; Aged; Drug Combinations; Female; Fibrinogen; Humans; Italy; Length of Stay; Lung Neoplasms; Male; Metastasectomy; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Pneumothorax; Reoperation; Surgical Stapling; Suture Techniques; Thrombin; Time Factors; Treatment Outcome | 2013 |
Comparison of the effects of pulmonary rehabilitation with chest physical therapy on the levels of fibrinogen and albumin in patients with lung cancer awaiting lung resection: a randomized clinical trial.
Topics: Aged; Anxiety; Breathing Exercises; Carcinoma, Non-Small-Cell Lung; Depression; Exercise; Exercise Test; Exercise Therapy; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Physical Endurance; Physical Exertion; Psychiatric Status Rating Scales; Quality of Life; Serum Albumin; Spirometry; Time Factors; Upper Extremity | 2014 |
Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women.
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Factor VII; Female; Fibrinogen; Hemostatics; Humans; Longitudinal Studies; Lung Neoplasms; Middle Aged; Postmenopause; Prognosis; Prospective Studies | 2016 |
Coagulation profile in patients undergoing video-assisted thoracoscopic lobectomy: A randomized, controlled trial.
Topics: Aged; Anticoagulants; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Postoperative Period; Thoracic Surgery, Video-Assisted; Thrombin; Thromboembolism | 2017 |
Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drainage; Drug Combinations; Electrocoagulation; Female; Fibrinogen; Humans; Length of Stay; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pneumonectomy; Postoperative Complications; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surgical Stapling; Thrombin; Tissue Adhesives; Treatment Outcome | 2009 |
Efficacy and safety of TachoSil® versus standard treatment of air leakage after pulmonary lobectomy.
Topics: Adult; Aged; Aged, 80 and over; Air; Chest Tubes; Drainage; Drug Combinations; Female; Fibrinogen; Humans; Length of Stay; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Pneumothorax; Postoperative Care; Postoperative Complications; Prospective Studies; Surgical Sponges; Surgical Stapling; Suture Techniques; Thrombin; Time Factors; Tissue Adhesives; Treatment Outcome | 2010 |
Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aprotinin; Carcinoma, Small Cell; Chest Tubes; Dalteparin; Drainage; Drug Combinations; Drug Therapy, Combination; Enoxaparin; Female; Fibrinogen; Fibrinolytic Agents; Hemostatics; Humans; Lung Neoplasms; Lymph Node Excision; Male; Mediastinum; Middle Aged; Prospective Studies; Thrombin; Thromboembolism; Time Factors | 2004 |
[Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
Topics: Adult; Aged; Antithrombins; Esophageal Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; International Normalized Ratio; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen Inactivators; Prospective Studies; Prothrombin Time; Thoracotomy; Venous Thrombosis | 2004 |
High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 2007 |
175 other study(ies) available for fibrinogen and Lung Neoplasms
Article | Year |
---|---|
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Genomics; Humans; Immune Evasion; Lung Neoplasms; Proteogenomics | 2021 |
MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Topics: Biomarkers; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Molecular Weight; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2022 |
Prognostic value of preoperative plasma fibrinogen levels in resected stage I non-small cell lung cancer.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Retrospective Studies | 2022 |
ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Neutrophils; Prognosis | 2022 |
Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Male; Neoplasm Recurrence, Local; Neutrophils; Prognosis; Retrospective Studies | 2022 |
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1-FGL1-MYH9 axis.
Topics: Adenocarcinoma of Lung; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Interleukin-2; Lung Neoplasms; Myosin Heavy Chains; YY1 Transcription Factor | 2022 |
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Neoadjuvant Therapy; Prognosis; Retrospective Studies | 2022 |
AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Fibrinogen; Humans; Interleukin-6; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Vascular Endothelial Growth Factor A | 2022 |
Suppression of CEBPδ recovers exhaustion in anti-metastatic immune cells.
Topics: Cell Line, Tumor; Fibrinogen; Humans; Killer Cells, Natural; Liver Neoplasms; Lung; Lung Neoplasms; RNA, Small Interfering; Tumor Microenvironment | 2023 |
Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer.
Topics: Adaptor Proteins, Vesicular Transport; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Fibrinogen; Humans; Lung Neoplasms; NLR Family, Pyrin Domain-Containing 3 Protein; Prognosis; RNA, Messenger; Signaling Lymphocytic Activation Molecule Family; Tumor-Associated Macrophages | 2023 |
The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Neutrophils; Prognosis; Retrospective Studies | 2023 |
Prognostic analysis of the plasma fibrinogen combined with neutrophil-to-lymphocyte ratio in patients with non-small cell lung cancer after radical resection.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Neutrophils; Prognosis; Retrospective Studies | 2023 |
Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: a retrospective study.
Topics: Carcinoma, Non-Small-Cell Lung; Fibrinogen; Humans; Hypertension; Lung Neoplasms; Multiple Pulmonary Nodules; Retrospective Studies | 2023 |
Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.
Topics: Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Hippo Signaling Pathway; Humans; Lung Neoplasms; Mice; MicroRNAs; RNA, Circular; Tumor Microenvironment | 2023 |
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung Cancer.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Fibrinogen; Humans; Lung Neoplasms; Prognosis | 2023 |
The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phosphopyruvate Hydratase; Retrospective Studies; Serpins; Sex Factors | 2019 |
FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules.
Topics: Biomarkers, Tumor; Diagnostic Tests, Routine; Exosomes; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Plasma; Proteomics; ROC Curve; Sensitivity and Specificity | 2019 |
FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Female; Fibrinogen; Hepatocytes; Humans; Immunoprecipitation; Lung Neoplasms; Male; Mass Spectrometry; Middle Aged; Molecular Targeted Therapy; Protein Array Analysis; Protein Isoforms; Protein Kinase Inhibitors; Proteomics | 2019 |
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer.
Topics: Aged; Biomarkers, Tumor; Blood Coagulation Disorders; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male; Pneumonectomy; Preoperative Period; Prognosis; Survival Rate; Thrombophilia; Venous Thromboembolism | 2020 |
FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Resistance, Neoplasm; Fibrinogen; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2020 |
Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Brain Neoplasms; CA-125 Antigen; Calcium; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Hemoglobins; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Partial Thromboplastin Time; Predictive Value of Tests; Reference Values; Retrospective Studies; Risk Factors; ROC Curve; Sensitivity and Specificity; Tumor Burden | 2021 |
The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fibrinogen; Humans; Lung Neoplasms; Lymphocytes; Neutrophils; Prognosis; Protein Kinase Inhibitors; Retrospective Studies | 2021 |
Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.
Topics: Animals; Apoptosis; Blotting, Western; Cancer-Associated Fibroblasts; Carcinoma, Lewis Lung; Cell Line; Chemokine CXCL12; Female; Fibrinogen; Flow Cytometry; Lung Neoplasms; Male; Mice; Mice, Knockout; Myeloid-Derived Suppressor Cells; Tumor Microenvironment | 2017 |
Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma.
Topics: Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2018 |
Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Topics: Aged; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Risk Factors; Serum Albumin, Human | 2018 |
Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
Topics: Aged; Aged, 80 and over; Albumins; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Propensity Score; Proportional Hazards Models; Survival Analysis | 2018 |
Hepato-entrained B220
Topics: Animals; CD11 Antigens; Female; Fibrinogen; Flow Cytometry; Humans; Interferon-gamma; Killer Cells, Natural; Leukocyte Common Antigens; Liver; Lung; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Precancerous Conditions | 2018 |
Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Blood Platelets; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Preoperative Care; Prognosis; Prospective Studies; Survival Rate | 2019 |
Role of preoperative blood markers as prognostic factors for lung cancer surgery.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Platelets; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Clinical Decision-Making; Databases, Factual; Female; Fibrinogen; Hemoglobins; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pneumonectomy; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2019 |
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Platinum Compounds; Proportional Hazards Models; ROC Curve; Serum Albumin | 2019 |
Plasma Fibrinogen and sP-Selectin are Associated with the Risk of Lung Cancer in a Prospective Study.
Topics: Adult; Aged; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Risk Factors; Selectins | 2019 |
[Activation of coagulation in patients with lung cancer].
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Platelet Activation; Prognosis | 2019 |
Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma of Lung; Adult; AMP-Activated Protein Kinase Kinases; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Fibrinogen; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neovascularization, Pathologic; Protein Serine-Threonine Kinases | 2019 |
Bronchial stump coverage with fibrin glue-coated collagen fleece in lung cancer patients who underwent pneumonectomy.
Topics: Adipose Tissue; Aged; Aprotinin; Bronchi; Bronchial Fistula; Drug Combinations; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Respiratory Tract Fistula; Retrospective Studies; Risk Factors; Thrombin; Treatment Outcome | 2014 |
Prevention of adhesions in redo surgery with TachoSil.
Topics: Drug Combinations; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Metastasectomy; Neoplasm Recurrence, Local; Pneumonectomy; Pneumothorax; Thrombin | 2013 |
Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.
Topics: Adult; Aged; alpha 1-Antitrypsin; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Female; Fibrinogen; Gene Expression; Humans; Keratin-10; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Protein Kinase Inhibitors; Proteomics; Retrospective Studies; Transferrin; Treatment Outcome | 2013 |
Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Serum; Survival Analysis | 2013 |
High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Partial Thromboplastin Time; Platelet Count; Smoking; Survival Rate; Young Adult | 2014 |
Imaging of thrombosis and microcirculation in mouse lungs of initial melanoma metastasis with in vivo cryotechnique.
Topics: Animals; Blood Coagulation; Blood Platelets; Cell Line, Tumor; Fibrinogen; Freezing; Glutathione; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activation; Platelet Aggregation; Quantum Dots; src-Family Kinases; Thrombosis | 2014 |
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis; Retrospective Studies | 2014 |
Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.
Topics: Aged; Blood Platelets; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Prognosis; Retrospective Studies; Survival Rate; Thrombocytosis | 2014 |
Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Predictive Value of Tests; Preoperative Period; Prognosis; Proportional Hazards Models | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Squamous Cell; Cecal Neoplasms; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Heart Diseases; Hemorrhage; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Multiple Organ Failure; Neoplasms, Multiple Primary; Organoplatinum Compounds; Postoperative Complications; Thrombosis; Tranexamic Acid; Vulvar Neoplasms | 2014 |
[Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Carcinoma, Non-Small-Cell Lung; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Normalized Ratio; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Partial Thromboplastin Time; Platelet Count; Prognosis; Prothrombin Time; Risk Factors; Survival Analysis; Thrombophilia; Young Adult | 2014 |
Application of ROTEM to assess hypercoagulability in patients with lung cancer.
Topics: Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemostasis; Humans; Lung Neoplasms; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Assessment; Thrombelastography; Thrombophilia; Treatment Outcome; Venous Thromboembolism | 2015 |
Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoassay; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Small Cell Lung Carcinoma | 2016 |
The impact of lung cancer resection surgery on fibrinogen and C-reactive protein and their relationship with patients outcomes: A prospective follow up study.
Topics: Aged; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Comorbidity; Cytokines; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Respiratory Function Tests; Treatment Outcome | 2016 |
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chromatography, High Pressure Liquid; Complement C3; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Peptides; Reproducibility of Results; ROC Curve; Solid Phase Extraction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
[Relationship between circulating tumor cells and coagulation factors in primary lung cancer patients].
Topics: Age Factors; Blood Platelets; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Keratins; Lung Neoplasms; Neoplastic Cells, Circulating | 2016 |
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Topics: Activins; Aged; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis | 2016 |
Prophylactic middle lobe fixation for postoperative pulmonary torsion.
Topics: Aged; Aprotinin; Drug Combinations; Female; Fibrinogen; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Patient Selection; Pneumonectomy; Retrospective Studies; Risk Assessment; Risk Factors; Thrombin; Time Factors; Torsion Abnormality; Treatment Outcome | 2017 |
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung.
Topics: Animals; Anticoagulants; Blood Coagulation; CD24 Antigen; Cell Line, Tumor; Fibrin; Fibrinogen; Heparin, Low-Molecular-Weight; Hirudins; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; P-Selectin; Receptor, PAR-1; Thromboplastin; Transplantation, Heterologous | 2009 |
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Topics: Carcinoma, Non-Small-Cell Lung; CD55 Antigens; CD59 Antigens; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Complement Activation; Complement Factor H; Complement System Proteins; Fibrinogen; Humans; Lung Neoplasms; Membrane Cofactor Protein | 2009 |
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; C-Reactive Protein; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fibrinogen; Humans; Inflammation; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Retrospective Studies | 2009 |
Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patients.
Topics: Aged; Anticoagulants; Blood Coagulation; Chromogenic Compounds; Factor X; Female; Fibrin; Fibrinogen; Heart Failure; Humans; International Normalized Ratio; Lung Neoplasms; Prothrombin Time; Time Factors; Warfarin | 2009 |
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.
Topics: C-Reactive Protein; Cohort Studies; Confounding Factors, Epidemiologic; Factor VIIa; Fibrinogen; Humans; Incidence; Leukocyte Count; Lung Neoplasms; Male; Neoplasms; Peptide Fragments; Prothrombin; Smoking; United Kingdom | 2010 |
[The changes of blood coagulation in surgical patients with lung cancer].
Topics: Adult; Aged; Blood Coagulation; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Prothrombin Time | 2010 |
Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.
Topics: Animals; Antigens, CD; Blood Coagulation; Blood Platelets; Cadherins; Fibrinogen; Immune System; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Protein C; Receptors, Lysosphingolipid; Thrombin | 2011 |
Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Brain Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunohistochemistry; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Receptors, Proteinase-Activated; Up-Regulation; Young Adult | 2012 |
Adipokines and systemic inflammation in weight-losing lung cancer patients.
Topics: Adiponectin; Aged; Aged, 80 and over; C-Reactive Protein; Cachexia; Carcinoma, Non-Small-Cell Lung; Ferritins; Fibrinogen; Humans; Leptin; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Platelet Count; Transferrin; Tumor Necrosis Factor-alpha | 2012 |
Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cell Line; Fibrinogen; Hemopexin; Histone Demethylases; Histones; Humans; Lung Neoplasms; Membrane Proteins; Pleural Effusion, Malignant; Pneumonia; Prealbumin; Proteome; Serum Amyloid P-Component; Tuberculosis, Pulmonary; Two-Dimensional Difference Gel Electrophoresis | 2012 |
Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome | 2012 |
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity | 2012 |
Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.
Topics: alpha-2-Antiplasmin; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 8; Caspase 9; Caspases; Dimerization; Electrophoresis, Polyacrylamide Gel; fas Receptor; Female; Fibrinogen; Humans; Jurkat Cells; Laminin; Lung Neoplasms; Male; Mass Spectrometry; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Signal Transduction; Ultraviolet Rays | 2002 |
Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.
Topics: Animals; Carcinoma, Lewis Lung; Cell Division; Fibrinogen; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Stromal Cells | 2002 |
Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans.
Topics: Cryoglobulins; Fibrinogen; Fibrinogens, Abnormal; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Thrombophlebitis | 1955 |
Fibrinolysis and fibrinogenemia in carcinoma of the lung.
Topics: Carcinoma; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms | 1961 |
[Significance of fibrinogen and hexosamine determination in blood in the differential diagnosis of pulmonary diseases].
Topics: Diagnosis, Differential; Fibrinogen; Hexosamines; Humans; Lung Diseases; Lung Neoplasms; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[THE VALUE OF SOME LABORATORY EXAMINATIONS IN DIFFERENT LUNG DISEASES, ESPECIALLY CARCINOMA].
Topics: Aniline Compounds; Blood Chemical Analysis; Blood Coagulation Tests; Diagnosis, Differential; Fibrinogen; Glycoproteins; Humans; Lung Diseases; Lung Neoplasms; Neuraminic Acids; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis | 1964 |
[ON THE FIBRINOGEN CONTENT OF THE BLOOD OF PATIENTS WITH PULMONARY TUBERCULOSIS AND WITH NON-TUBERCULOUS LUNG DISEASES].
Topics: Blood Protein Electrophoresis; Blood Sedimentation; Fibrinogen; Humans; Leukocytosis; Lung Neoplasms; Pneumonia; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Topics: Animals; Chick Embryo; Chickens; Chorion; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Lung Neoplasms; Neovascularization, Pathologic; Pleural Effusion; Rabbits; Tumor Virus Infections | 2004 |
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer.
Topics: Animals; Blood Platelets; Bone Marrow; Carcinoma, Lewis Lung; Cell Adhesion; Cell Proliferation; Chemotaxis; Cyclin D2; Cyclins; Disease Progression; Endothelial Cells; Female; Fibrinogen; Hepatocyte Growth Factor; Humans; Interleukin-8; Lung Neoplasms; Matrix Metalloproteinase 14; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Platelet Activation; Platelet Membrane Glycoproteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.
Topics: Adenocarcinoma; Animals; Blood Coagulation; Blood Platelets; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Fibrinogen; Fibrosarcoma; Hirudins; Humans; Lung; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Rats; Thrombin | 2004 |
Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Preoperative Care; Prognosis | 2006 |
Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchial Fistula; Bronchial Spasm; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Empyema, Pleural; Female; Fibrinogen; Fistula; Humans; Intraoperative Period; Life Tables; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Retrospective Studies; Risk; Sex Factors; Smoking; Sputum; Survival Analysis; Survival Rate | 2006 |
The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Colonic Neoplasms; Endothelial Cells; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Morphogenesis; Mutation; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sequence Deletion; Transfection | 2006 |
Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2).
Topics: Cell Proliferation; Drug Synergism; Fibrinogen; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; RNA, Small Interfering; Tumor Cells, Cultured | 2008 |
Coagulation properties of human thoracic duct lymph.
Topics: Blood Coagulation Factors; Erythrocyte Count; Factor V; Factor VII; Factor X; Fibrinogen; Fibrinolysis; Gastrointestinal Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Neoplasms; Lymph; Prothrombin; Prothrombin Time; Thoracic Duct; Thromboplastin | 1967 |
[Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. In pathologically verified lung cancer. II. In thrombotic/embolic occurrences].
Topics: Antineoplastic Agents; Biopsy; Blood Coagulation Tests; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lung; Lung Neoplasms; Pulmonary Embolism; Streptokinase; Thromboembolism; Thrombophlebitis | 1981 |
IgA nephropathy associated with bronchial small-cell carcinoma.
Topics: Aged; Carcinoma, Small Cell; Complement C3; Fibrinogen; Humans; Immunoglobulin A; Kidney Diseases; Kidney Glomerulus; Lung Neoplasms; Male; Middle Aged; Vasculitis | 1981 |
Peptides cleaved from fibrinogen by plasmin enhance the progression of L-1 sarcoma in BALB/c mice.
Topics: Animals; Fibrinogen; Fibrinolysin; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Peptides; Sarcoma, Experimental | 1981 |
Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Tests; Cyclophosphamide; Dacarbazine; Female; Fibrinogen; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Piperazines; Platelet Aggregation; Platelet Count; Razoxane; Triazenes | 1984 |
Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth.
Topics: Aged; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prognosis; Prothrombin Time; Warfarin | 1983 |
[Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Topics: Adult; Animals; Blood Coagulation; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Radioimmunoassay; Swine; Thrombosis | 1982 |
Effect of defibrination with batroxobin on growth and metastasis of JW sarcoma in mice.
Topics: Animals; Batroxobin; Drug Administration Schedule; Fibrinogen; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Peptide Hydrolases; Sarcoma, Experimental; Transplantation, Isogeneic | 1980 |
[Trauma, fibrinogen levels and metastasis formation in experimental oncology].
Topics: Animals; Blood Coagulation; Carcinoma 256, Walker; Female; Fibrinogen; Lung Neoplasms; Rats; Rats, Inbred Strains; Wounds and Injuries | 1982 |
Blood coagulation changes in JW sarcoma, a new metastasizing tumour in mice.
Topics: Animals; Blood Cell Count; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neoplasm Transplantation; Sarcoma, Experimental | 1980 |
[First clinical experience with large volume plasma exchange in malignant tumor patients].
Topics: Adrenal Cortex Hormones; Adult; Carcinoma, Basal Cell; Drug Combinations; Fibrinogen; Hodgkin Disease; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lung Neoplasms; Lymphoma; Middle Aged; Plasma Exchange; Plasmapheresis; Prothrombin | 1980 |
[The difference between carcinomatous and tuberculous pleural fluid in fibrin and fibrinogen metabolism (author's transl)].
Topics: Fibrin; Fibrinogen; Humans; Lung Neoplasms; Pleural Effusion; Tuberculosis, Pulmonary | 1981 |
Tumour sublines with different metastatic capacity induce similar blood coagulation changes in the host.
Topics: Animals; Blood Coagulation; Cell Line; Fibrinogen; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Sarcoma, Experimental | 1981 |
Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Blood Coagulation; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Granulocytes; Humans; Leukocyte Elastase; Lung Neoplasms; Male; Middle Aged; Pancreatic Elastase; Partial Thromboplastin Time; Peptide Hydrolases; Prothrombin Time | 1993 |
[Levels of VIIIR:Ag, VIII:C and fibrinogen in plasma of patients with lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Factor VIII; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; von Willebrand Factor | 1994 |
[Study on advanced non-small cell lung cancer patients with Qi deficiency and blood stasis syndrome].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fibrinogen; Humans; Immunity, Cellular; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; T-Lymphocyte Subsets; Thromboxane B2 | 1994 |
Serum levels of interleukin 6 in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fibrinogen; Humans; Interleukin-6; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Platelet Count; Serum Albumin | 1995 |
Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of Veterans Affairs Cooperative Study 188.
Topics: Carcinoma, Small Cell; Cohort Studies; Drug Resistance; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Lung Neoplasms; Mopidamol; Randomized Controlled Trials as Topic; Regression Analysis; Thrombin | 1995 |
Amino acids and peptides. XXV. Preparation of fibronectin-related peptide poly(ethylene glycol) hybrids and their inhibitory effect on experimental metastasis.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Fibrinogen; Lung Neoplasms; Mice; Molecular Sequence Data; Neoplasm Metastasis; Oligopeptides; Polyethylene Glycols | 1995 |
Lung cancer producing interleukin-6.
Topics: Biopsy; C-Reactive Protein; Carcinoma, Large Cell; Fatal Outcome; Fibrinogen; Humans; Immunohistochemistry; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Radiography | 1996 |
Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Cell Line; Dexamethasone; Epithelial Cells; Epithelium; Fibrinogen; Humans; Interleukin-6; Intestines; Kidney Neoplasms; Liver Neoplasms; Lung; Lung Neoplasms; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Primary pulmonary malignant hemangiopericytoma associated with coagulopathy.
Topics: Adult; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Loss, Surgical; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemangiopericytoma; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Pneumonectomy; Postoperative Hemorrhage; Thrombophlebitis | 1997 |
N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.
Topics: Animals; Cell Adhesion; Cell Adhesion Molecules; Extracellular Matrix Proteins; Fibrinogen; Formamides; Humans; Integrins; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
Topics: Adenocarcinoma; Biomarkers, Tumor; C-Reactive Protein; Diagnosis, Differential; Fibrinogen; Humans; Interleukin-6; Lung Neoplasms; Mesothelioma; Orosomucoid; Pleural Effusion; Pleural Neoplasms; Pleurisy; Survival Analysis; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1998 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia; Diagnosis, Differential; Disease Progression; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhagic Disorders; Humans; Lung Neoplasms; Paraneoplastic Syndromes; Tranexamic Acid | 1998 |
Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged | 1998 |
The procoagulant state of the VX-2 tumor in rabbit lung in vivo--relative accumulation of fibrinogen, prothrombin, plasminogen, antithrombin and heparin cofactor II within the tumor.
Topics: Animals; Antithrombins; Fibrinogen; Hemostasis; Heparin Cofactor II; Lung Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Plasminogen; Prothrombin; Rabbits | 1999 |
Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fibrinogen; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Pleural Effusion, Malignant | 2000 |
Role of fibrinogen covalently associated with cell membrane in blood-borne lung tumor colony formation of murine mammary carcinoma cells.
Topics: Animals; Anticoagulants; Cell Membrane; Fibrinogen; Glucocorticoids; Heparin; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Prednisolone; Whole Blood Coagulation Time | 2000 |
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.
Topics: Animals; Carcinoma, Lewis Lung; Cell Adhesion; Disease Models, Animal; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hirudins; Histocytochemistry; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Thrombin | 2000 |
Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Prognosis; Reference Values; Risk Factors; Serine Proteinase Inhibitors; Survival Rate | 2001 |
Pulmonary metastasis formation after intravenous tumour cell injection in defibrinogenated rats.
Topics: Animals; Batroxobin; Blood Coagulation; Dextrans; Female; Femoral Fractures; Fibrinogen; Lung Neoplasms; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation; Rats; Rats, Inbred Strains; Wounds and Injuries | 1976 |
Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis.
Topics: Adult; Aged; Animals; Blood Coagulation Disorders; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Thromboembolism; Thromboplastin | 1975 |
Effect of human serum plus streptokinase on spontaneous pulmonary metastases of Vx2 carcinomas transplanted in the maxillary sinus of the rabbit.
Topics: Animals; Blood; Carcinoma; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male; Maxillary Neoplasms; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Rabbits; Serum Globulins; Streptokinase | 1975 |
Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Erythrocytes; Fibrinogen; Injections, Intramuscular; Injections, Intravenous; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors; Transplantation, Isogeneic | 1977 |
In vitro pleural fluid clottability and fibrinogen content.
Topics: Adult; Arthritis, Rheumatoid; Blood Coagulation Tests; Blood Proteins; Female; Fibrinogen; Fibrinolysis; Heart Failure; Hodgkin Disease; Humans; In Vitro Techniques; Liver Cirrhosis; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Tuberculosis, Pulmonary | 1975 |
Prognostic significance of blood coagulation tests in carcinoma of the lung and colon.
Topics: Blood Coagulation Tests; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung Neoplasms; Multivariate Analysis; Partial Thromboplastin Time; Platelet Count; Prognosis; Prospective Studies | 1992 |
[Analysis of adhesive proteins on the surface of platelets from the patients with lung cancer: studies in histological type and clinical stage].
Topics: Adenocarcinoma; Blood Platelets; Carcinoma, Squamous Cell; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fibronectins; Flow Cytometry; Humans; Lung Neoplasms; Platelet Membrane Glycoproteins; Thrombospondins | 1992 |
[Thrombosis-inducing activity (TIA) in plasma of a patient with lung cancer, which disappeared after radiotherapy].
Topics: Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Pancoast Syndrome | 1992 |
Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Blood Coagulation; Cell Death; Cytotoxicity, Immunologic; Female; Fibrin; Fibrinogen; Humans; Immunity, Cellular; Interleukin-2; Killer Cells, Lymphokine-Activated; Kinetics; Leukocytes, Mononuclear; Lung Neoplasms; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombin | 1992 |
Autologous fibrin glue--preparation and clinical use in thoracic surgery.
Topics: Blood Transfusion, Autologous; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Pneumonectomy | 1992 |
Fibrinolytic profiles in patients with small cell carcinoma of the lung.
Topics: Carcinoma, Small Cell; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male | 1991 |
Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Antibodies; Antibodies, Monoclonal; Biomarkers; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Fibronectins; Humans; Immunohistochemistry; Inflammation; Keratins; Ki-67 Antigen; Lung Neoplasms; Macrophages; Nuclear Proteins; Plasminogen Inactivators; T-Lymphocytes; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1991 |
Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Platelet Count; Tegafur; Thrombosis; Vindesine | 1992 |
[Blood coagulation disorders and tumor growth].
Topics: Adult; Anticoagulants; Antineoplastic Agents; Blood Coagulation Disorders; Breast Neoplasms; Cell Line; Cells, Cultured; Drug Therapy, Combination; Female; Fibrin; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Stomach Neoplasms; Surface Properties; Tumor Cells, Cultured | 1991 |
Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung.
Topics: Blood Coagulation; Carcinoma, Small Cell; Factor V; Fibrin; Fibrinogen; Fibrinolysis; Glycoproteins; Humans; Immunohistochemistry; Lung Neoplasms; Plasminogen Activators; Plasminogen Inactivators; Protein C; Protein S | 1990 |
Investigations concerning the potential for using 1H NMR relaxometry or high-resolution spectroscopy of plasma as a screening test for malignant lung disease.
Topics: Blood Proteins; Female; Fibrinogen; Humans; Lipoproteins; Lung Diseases; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Mathematics; Pregnancy | 1990 |
Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.
Topics: Animals; Antibodies; Batroxobin; Fibrinogen; G(M1) Ganglioside; Glycosphingolipids; Killer Cells, Natural; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Poly I-C; Serine Endopeptidases | 1990 |
[Loco-regional cancer chemotherapy in patients with malignant pleural effusion--improving the QOL of patients].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Delayed-Action Preparations; Doxorubicin; Drug Evaluation; Factor XIII; Female; Fever; Fibrinogen; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pleural Neoplasms; Quality of Life; Thrombin; Vomiting | 1990 |
[Endoscopic management of bronchial stump fistulas with fibrin glue].
Topics: Adult; Aprotinin; Bronchial Fistula; Bronchoscopy; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Complications; Surgical Wound Dehiscence; Thrombin | 1986 |
[Endoscopic closure of the postoperative bronchopleural fistula].
Topics: Aged; Aprotinin; Bronchial Fistula; Bronchoscopy; Carcinoma, Squamous Cell; Drainage; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Fistula; Humans; Lung Neoplasms; Male; Pleural Diseases; Pneumonectomy; Postoperative Complications; Thrombin | 1988 |
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells.
Topics: Adenocarcinoma; Amino Acid Sequence; Blotting, Northern; Cell Adhesion; Cell Line; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Fibroblasts; Fibronectins; Glycoproteins; Humans; Integrins; Lung Neoplasms; Melanoma; Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; RNA, Messenger; Vitronectin; von Willebrand Factor | 1989 |
Treatment of postoperative chylothorax with intrapleural fibrin glue.
Topics: Adenocarcinoma; Aged; Aprotinin; Chylothorax; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Lung Neoplasms; Male; Postoperative Complications; Thrombin; Tissue Adhesives | 1989 |
Presence of thrombosis-inducing activity in plasma from patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Animals; Carcinoma, Squamous Cell; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guinea Pigs; Humans; Lung Diseases; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Platelet Count; Thrombosis | 1989 |
Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung.
Topics: Antibodies, Monoclonal; Carcinoma, Small Cell; Fibrin; Fibrinogen; Humans; Immunoenzyme Techniques; Lung Neoplasms | 1988 |
[Fibrolamellar hepatocarcinoma with a long clinical course and possible production of fibrinogen].
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged | 1986 |
[Effect of therapy with cytostatic drugs on the hemostasis system in patients with small cell and non-small cell bronchial cancers, malignant lymphomas and plasmacytomas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fibrinogen; Fibrinopeptide A; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Plasmacytoma | 1986 |
Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
Topics: Adenocarcinoma; Amino Acid Sequence; Cell Line; Fibrin; Fibrinogen; Humans; Immunodiffusion; Kinetics; Lung Neoplasms; Molecular Weight; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1986 |
[The inhibitory effect of batroxobin against the lung metastasis of the B16-F10 melanoma cells implanted in the mice in relation to the activity of the NK cell].
Topics: Animals; Batroxobin; Cytotoxicity, Immunologic; Fibrinogen; Killer Cells, Natural; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Serine Endopeptidases | 1988 |
Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.
Topics: Ancrod; Animals; Anticoagulants; Blood Coagulation Factors; Female; Fibrin; Fibrinogen; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1988 |
[Role of natural killer cells in the antimetastatic effect of defibrinogenation with batroxobin].
Topics: Animals; Batroxobin; Fibrinogen; Killer Cells, Natural; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Peptide Hydrolases; Poly I-C | 1987 |
Use of fibrin glue in thoracic surgery.
Topics: Aged; Bronchial Fistula; Carcinoma, Squamous Cell; Drug Combinations; Empyema; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Hernia, Hiatal; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Complications; Radiography; Thrombin; Wound Healing | 1985 |
Fate of intravenously injected human tumor cells in the lung of nude mice following whole-body X-irradiation.
Topics: Animals; Blood Coagulation; Carcinoma, Squamous Cell; Cytotoxicity, Immunologic; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Killer Cells, Natural; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Whole-Body Irradiation | 1985 |
The role of blood platelet and fibrinogen in experimental metastasis in nude mice following whole body X-irradiation.
Topics: Animals; Blood Platelets; Carcinoma, Squamous Cell; Fibrinogen; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Platelet Count; Whole-Body Irradiation | 1985 |
Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Female; Fibrin; Fibrinogen; Follow-Up Studies; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; N-Acetylneuraminic Acid; Nephrectomy; Paraneoplastic Syndromes; Sialic Acids; Thrombin Time | 1985 |
Hepatocellular carcinoma with the carcinoid syndrome.
Topics: Acid Phosphatase; Adult; Albumins; Bile Acids and Salts; Carcinoma, Hepatocellular; Esterases; Fibrinogen; Glycogen; Histocytochemistry; Humans; Hydroxyindoleacetic Acid; Lipids; Lipoproteins; Liver Neoplasms; Lung Neoplasms; Male; Malignant Carcinoid Syndrome; Microscopy, Electron; Peroxidases; Serotonin; Staining and Labeling; Transferrin | 1971 |
Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Alpha-Globulins; Blood Coagulation Disorders; Blood Protein Electrophoresis; Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Infusions, Parenteral; Lung Neoplasms; Macroglobulins; Male; Middle Aged; Time Factors | 1973 |
[Indicators of blood coagulation system in determination of the degree of expansion of the process in cancer].
Topics: Adult; Aged; Blood Coagulation; Fibrinogen; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms | 1973 |
[Cryoglobulin (cryofibrinogen) in tumor patients].
Topics: Blood Protein Disorders; Breast Neoplasms; Cryoglobulins; Diagnosis, Differential; Fibrinogen; gamma-Globulins; Humans; Lung Neoplasms; Neoplasms | 1966 |
Coagulation abnormalities in patients with inoperable lung cancer.
Topics: Aged; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemoptysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Plasminogen; Prothrombin Time; Thrombin; Thrombophlebitis; Thromboplastin | 1974 |
The role of heparin in the chemotherapy of solid tumors: preliminary clinical trial in carcinoma of the lung.
Topics: Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Fibrinogen; Fluorouracil; Heparin; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Thioguanine; Vincristine | 1972 |
Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Blood Coagulation; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Fibrinogen; Fluorouracil; Heparin; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Radiography; Skin Neoplasms; Thioguanine; Vincristine | 1974 |
Fibrinogen degradation products in serum from patients with cancer.
Topics: Aminocaproates; Blood Coagulation; Breast Neoplasms; Colonic Neoplasms; Female; Fibrin; Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Humans; Immunoelectrophoresis; Intestinal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Thrombin; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1973 |
[Correlations between the content of fibrinogen and corticosteroids in the blood in malignant neoplasms].
Topics: 11-Hydroxycorticosteroids; Adult; Aged; Cortisone; Fibrinogen; Humans; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Photometry; Stomach Neoplasms | 1973 |
Microangiopathic haemolytic anaemia and experimental tumour-cell emboli.
Topics: Aminocaproates; Anemia, Hemolytic; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Carcinoma 256, Walker; Chromium Radioisotopes; Embolism; Female; Fibrinogen; Hemoglobinometry; Heparin; Injections, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Microscopy, Electron; Rats; Triamcinolone Acetonide | 1974 |
[Biochemical diagnosis of thrombosis and thromboembolism of the pulmonary artery following pneumonectomy].
Topics: Adult; Blood Coagulation Tests; Fibrinogen; Humans; Lung Neoplasms; Middle Aged; Pneumonectomy; Postoperative Complications; Pulmonary Artery; Thromboembolism; Thrombosis | 1971 |
[Blood levels of fibrinogen, free heparin and fibrinolytic activity in patients with chronic suppurations of the lungs].
Topics: Blood Coagulation; Fibrinogen; Fibrinolysis; Heparin; Humans; Lung Diseases; Lung Neoplasms; Suppuration | 1971 |
Autoradiographic study on localization of fibrinogen in rabbit lung cancer.
Topics: Adenocarcinoma; Animals; Autoradiography; Carcinogens; Carcinoma, Squamous Cell; Fibrinogen; Iodine Isotopes; Lung; Lung Neoplasms; Methylcholanthrene; Neoplasms, Experimental; Quinolines; Rabbits | 1971 |
[Potentiation of antineoplastic agents--significance of combination with urokinase].
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Dextrans; Drug Synergism; Female; Fibrinogen; Fibrinolytic Agents; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Rectal Neoplasms; Sarcoma, Yoshida; Splenic Neoplasms; Stomach Neoplasms | 1971 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea | 1969 |
[Clinical significance of blood coagulation studies in lung surgery].
Topics: Blood Coagulation; Blood Coagulation Disorders; Cysts; Fibrinogen; Fibrinolysis; Heparin; Humans; Inflammation; Lung Diseases; Lung Neoplasms; Pneumonectomy; Postoperative Complications; Suppuration; Thrombosis; Time Factors | 1969 |
[Indices of hemostasis in radiotherapy of cancer of the lung].
Topics: Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Radiation Effects | 1970 |
Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Breast Neoplasms; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Mucins; Neoplasm Metastasis; Stomach Neoplasms; Thrombocytopenia; Thrombosis | 1970 |
Localization of radioiodinated fibrinogen in invaded and metastasized tumor tissue of Walker carcinosarcoma.
Topics: Animals; Autoradiography; Carcinoma 256, Walker; Female; Fibrinogen; Histocytochemistry; Iodine Isotopes; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Peritoneal Neoplasms; Rats | 1970 |
Extrapulmonary effects of cancer of the lung and pleura. Endocrine, muscular, cutaneous, hematologic, and cardiovascular manifestations not due to metastases.
Topics: Adult; Agammaglobulinemia; Aged; Anemia; Biopsy; Cardiovascular Diseases; Cerebellar Diseases; Connective Tissue; Dermatomyositis; Endocarditis; Endocrine System Diseases; Fibrinogen; Hematologic Diseases; Humans; Hyperparathyroidism; Lung Neoplasms; Male; Microscopy, Electron; Middle Aged; Mitral Valve; Neuromuscular Diseases; Photomicrography; Pleural Neoplasms; Polycythemia; Radiography; Skin Manifestations | 1971 |
[Effect of stressing stimuli on fibrinogen, hematic fibrinolysis and production of pulmonary metastases].
Topics: Animals; Carcinoma 256, Walker; Female; Fibrinogen; Fibrinolysis; Lung Neoplasms; Neoplasm Metastasis; Nephrectomy; Rats; Stress, Physiological | 1967 |
[Determination of fibrinogen and fibrinolytic activity of the blood in lung cancer, chronic non-specific pneumonia and exudative pleuritis].
Topics: Adult; Chronic Disease; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Pleurisy; Pneumonia | 1967 |
[Diagnostic value of the plasma fibrinogen livel in lung cancer].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Lung Neoplasms; Tuberculosis, Pulmonary | 1968 |
[State of the anticoagulant system in patients with cancer as an indication of the reactivity of the organism].
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Breast Neoplasms; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Lung Neoplasms; Neoplasms; Skin Tests; Stomach Neoplasms | 1968 |
Fibrinogen levels and pulmonary metastases in rats. Effect of tissue damage.
Topics: Animals; Blood Coagulation Tests; Carcinoma 256, Walker; Factor VII; Factor VIII; Female; Fibrinogen; Lung Neoplasms; Neoplasm Metastasis; Nephrectomy; Rats; Stress, Physiological; Time Factors | 1969 |
[Increase in pulmonary metastases after partial hepatectomy: plasma coagulation and fibrinogen].
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Carcinoma 256, Walker; Fibrinogen; Hematocrit; Hepatectomy; Lung Neoplasms; Neoplasm Metastasis; Postoperative Complications; Rats | 1969 |
[Significance of fibrinogen level in neoplastic and other diseases of the lung].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Lung Diseases; Lung Neoplasms | 1969 |
[Comparison of the results of the Brdicka reaction with fibrinogen level and fibrinolysis of plasma euglubolins for the diagnosis of malignant neoplasms].
Topics: Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Hodgkin Disease; Humans; Lung Neoplasms; Methods; Neoplasms; Peptic Ulcer; Polarography | 1969 |
Coagulation factors in human lymph and plasma.
Topics: Anticoagulants; Antithrombins; Blood Coagulation Factors; Factor V; Factor VIII; Fibrinogen; Humans; Liver Cirrhosis; Lung Neoplasms; Lymph; Pancreatitis; Prothrombin; Thoracic Duct | 1965 |
[Importance of the blood plasma fibrinogen determination in differential diagnosis of lung cancer and tuberculosis].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Lung Neoplasms; Tuberculosis, Pulmonary | 1965 |
Fibrinogen and antibodies to fibrin as carrier of 131-I for cancer therapy.
Topics: Aminocaproates; Animals; Antibodies; Brain Neoplasms; Carcinoma 256, Walker; Dogs; Female; Fibrinogen; Hot Temperature; Humans; Immune Sera; Injections, Intravenous; Iodine Isotopes; Lung Neoplasms; Male; Neoplasm Metastasis; Rabbits; Radionuclide Imaging; Rats | 1965 |
[Functional disturbances of the liver in primary carcinoma of the lung].
Topics: Blood Protein Disorders; Fibrinogen; Humans; Liver; Liver Function Tests; Lung Neoplasms; Prothrombin | 1965 |